Press Releases - Lupin Limited

HOME

LUPIN FOUNDATION

CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.

CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

Menu

PRESS RELEASES

Intimation sent to the BSE/NSE in connection with change in the partnership interest of the Company in ABCD Technologies LLP

April 01, 2021

LupinLife Partners with Uttarakhand Police to Promote Hand Hygiene at Kumbh Mela 2021

March 24, 2021

Lupin Launches Authorized Generic Version of Alinia®

March 10, 2021

Lupin Pharma Canada Announces Partnership with Endoceutics for the commercialization of Intrarosa®

March 09, 2021

Lupin Launches Penicillamine Tablets USP

March 02, 2021

Lupin Receives Approval for Droxidopa Capsules

February 19, 2021

Lupin Launches Posaconazole Delayed-Release Tablets

February 17, 2021

LupinLife Launches Be One, Ayurvedic Energy Supplement

February 10, 2021

Lupin Receives Approval for Tavaborole Topical Solution

February 09, 2021

Lupin Announces Appointment of New Independent Director

February 02, 2021

Lupin Quarter III FY2021 Results

January 28, 2021

Lupin Receives Approval for Sevelamer Carbonate Tablets

January 25, 2021

Notice of Q3 FY2021 Board Meeting

January 14, 2021

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

January 07, 2021

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

January 06, 2021